๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies

โœ Scribed by Daisuke Tsuji; Yukari Higashine; Kazuhiko Matsuoka; Hitoshi Sakuraba; Kohji Itoh


Book ID
116347434
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
387 KB
Volume
378
Category
Article
ISSN
0009-8981

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effect of a chimeric anti-ganglioside GM
โœ Hisao Fukumoto; Kazuto Nishio; So Ohta; Nobuo Hanai; Kazuya Fukuoka; Yuichiro Oh ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 264 KB

Ganglioside GM2 is expressed on the surface of neuroblastoma and glioblastoma cells, and may also be detected on lung cancer cells. We reported previously that anti-ganglioside GM2 antibody exhibited strong in vitro anti-tumor activity against adriamycin-resistant cancer cells, which overexpressed g

Reversal of adriamycin resistance with c
โœ Hisao Fukumoto; Kazuto Nishio; So Ohta; Nobuo Hanai; Nagahiro Saijo ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 604 KB

Ganglioside GH2 is one of the major cell-surface gangliosides expressed in human tumors. We earlier established a mouse/ human IgG I chimeric anti-GM2 antibody, KM966, which displayed anti-tumor activity in human tumor cells both in vitro and in vivo. In this study, we have screened for changes in g